Professor, Dermatology, Stanford University Medical Center

Dermatology

Anthony is an expert in the field of Dermatology. He graduated from University of California San Diego School of Medicine. University of California San Diego School of Medicine is ranked 17/19 in Research/PrimaryCare. He received awards:"Elected Member" and "CMS Meaningful Use Stage 1 Certification". Anthony is a published physician. He published 41 publications, including: 'An Investigator-Initiated Open-label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.' He accepts Medicare.

Publications

---

• An Investigator-Initiated Open-label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.
• Smoothened variants explain the majority of drug resistance in Basal cell carcinoma.
• Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma.
• Human COL7A1-corrected induced pluripotent stem Cells for the treatment of recessive dystrophic epidermolysis bullosa.
• Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.
• An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk Basal cell carcinoma.
• "Atypical" regulation of hedgehog-dependent Cancers.
• Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.
• Partial proteasome inhibitors induce Hair follicle growth by stabilizing ß-catenin.
• "Patch"ing Up Our Tumor Signaling Knowledge.
• Perivascular Hair Follicle Stem Cells Associate with a Venule Annulus.
• Rapid genetic analysis of epithelial-mesenchymal signaling during Hair regeneration.
• Markedly improved overall survival in 10 consecutive metastatic Basal cell carcinoma patients.
• GLI activation by atypical protein kinase C ?/? regulates the growth of Basal cell carcinomas.
• Shh maintains dermal papilla identity and Hair morphogenesis via a Noggin-Shh regulatory loop.
• Neuropilins are positive regulators of Hedgehog signal transduction.
• Top-accessed article: Basal cell nevus syndrome.
• SnapShot: Hair Follicle Stem Cells.
• Cell migration: GSK3β steers the cytoskeleton's tip.
• MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling.
• BAR domain competition during directional Cellular migration.
• I-BAR protein antagonism of endocytosis mediates directional sensing during guided Cell migration.
• The primary cilium: a small yet mighty organelle.
• Laminin-511 is an epithelial message promoting dermal papilla development and function during early Hair morphogenesis.
• Controlling Hair follicle signaling pathways through polyubiquitination.
• Dermatology in the postgenomic era: harnessing human variation for personalized medicine.
• A new role for an old friend: NFAT and stem Cell quiescence.
• Role of the Basement Membrane Zone in Skin Development.
• The primary cilia, a 'Rab-id' transit system for hedgehog signaling.
• Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal Cells and can promote tumor Cell proliferation.
• Dual degradation signals control Gli protein stability and tumor formation.
• Mammalian variations on a theme: a Smo and Sufu surprise.
• Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4.
• MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription.
• Leukemia cutis presenting as a Sister Mary Joseph nodule.
• Eruptive xanthomas associated with olanzapine use.
• Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis.
• Hair cycle regulation of Hedgehog signal reception.
• Advanced Treatment for Basal Cell Carcinomas.
• Augmenting endogenous wnt signaling improves Skin wound healing.

Schools

---

• University Of California San Diego School Of Medicine

• Stanford University Hospital

Procedures Preformed

---

• Destruction of Benign Skin Lesion
• Excision of Benign Skin Lesion
• Excision of Malignant Skin Lesion
• Mohs Surgery
• View All

Conditions Treated

---

• Actinic Keratosis
• Athlete's Foot
• Atopic Dermatitis (Eczema)
• Basal Cell Carcinoma
• View All

Doctors Specialties

---

• Dermatology

Accepted Insurances

---

Awards

---

• Elected Member
• CMS Meaningful Use Stage 1 Certification

Education

---

• Stanford University
• University of California San Diego School of Medicine

Hospital

---

• VA Palo Alto Health Care System
• Stanford Health Care

Drug Facts

---

NPI NUMBER		1902963853
NPPES Provider LastName		ORO
NPPES Provider FirstName		ANTHONY
NPPES Provider ZIPCode		943042201
NPPES Provider State		CA
Specialty Description		Dermatology
Total Claim Count		204.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1902963853
Last Name Of The Provider	ORO
First Name Of The Provider	ANTHONY
View All

Similar Doctors

---

	Dr. Meghan M. Dickman, MD
	Dr. Erik S. Cabral, MD This Doctor is OpenDoctor Recommended.
	Dr. Kavita Y. Sarin, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas G. Munyon, MD This Doctor is OpenDoctor Recommended.
	Dr. Carol S. Chan, MD This Doctor is OpenDoctor Recommended.
	Dr. Youn-Hee Kim, MD
	Dr. Cynthia Y. Ng, MD This Doctor is OpenDoctor Recommended.
	Dr. Jean Y. Tang, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Bryan K. Sun, MD This Doctor is OpenDoctor Recommended.
	Dr. Joanna Badger, MD This Doctor is OpenDoctor Recommended.
	Dr. David H. Peng, MD This Doctor is OpenDoctor Recommended.
	Dr. Amrita Arora, MD This Doctor is OpenDoctor Recommended.
	Dr. Laura L. Bernet, MD
	Dr. Bernice Y. Kwong, MD This Doctor is OpenDoctor Recommended.
	Dr. Kevin C. Wang, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog